Je was op zoek naar: 1 339 (IJslands - Engels)

1
1

1.
1st

% 1
debug in %1

% 1%
byte array

1 poki
1 bag

1 = væg
1 = mild

1 (1%)
act 1 data).

(1. sinn)
(1st time)

<1/10)
(≥1/100 to <1/10)

1 blettunaráhald
1 applicator of

+ 1 millistykki
+ 1 bottle adapter

((innsíða 1))
((inside 1))

1. (upphaf)
1 (start)

206 ml p=0,003 (73; 339)
(73, 339)

hrvatska sanofi-aventis croatia d.o.o tel: + 385 1 46 68 339
hrvatska sanofi-aventis croatia d.o.o tel: + 385 1 6003 400

339 sjúklingar (225 fengu verteporfin, 114 fengu lyfleysu) tóku þátt í þessari rannsókn.
339 patients (225 verteporfin, 114 placebo) were enrolled in this study.

Í klínískri rannsókn fengu 670 fyrirburar, fæddir eftir 27-36 vikna meðgöngu, rotarix og 339 fengu lyfleysu.
in a clinical study, 670 pre-term infants from 27 to 36 weeks of gestational age were administered rotarix and 339 received placebo.

Í klínískri rannsókn fengu 670 fyrirburar, fæddir eftir 27-36 vikna meðgöngu, frostþurrkað form rotarix og 339 fengu lyfleysu.
in a clinical study, 670 pre-term infants from 27 to 36 weeks of gestational age were administered rotarix lyophilised formulation and 339 received placebo.

af 339 nýrnaþegum sem fengu meðferð með basiliximabi og voru prófaðir fyrir and-kjarngerðarmótefnum (anti-idiotype antibodies), sýndu 4 (1,2%) and-kjarngerðarmótefnasvörun.
of 339 renal transplant patients treated with basiliximab and tested for anti-idiotype antibodies, 4 (1.2%) developed an anti-idiotype antibody response.